Brief: Bellicum Pharmaceuticals Reports Q1 Loss Per Share Of $0.68
08/05/2018 23:43
May 8 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018
FINANCIAL
RESULTS
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON
SHAREHOLDERS
$0.68
* Q1 EARNINGS PER SHARE VIEW $-0.69 -- THOMSON REUTERS
I/B/E/S
* QTRLY GRANT REVENUE $154,000 VERSUS $128,000
* Q1 REVENUE VIEW $32860.00 -- THOMSON REUTERS I/B/E/S
Source text for Eikon: urn:newsml:reuters.com:*:nGNXn8FTb
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview